An appropriate study design and methylation detection technique are required to demonstrate a possible epigenetic lineage of tumor cells, such as that indicated by a sequence of risk factor-increased methylation of ANKRD34B and/or ZIC1 in normal cells and a further increase in derived tumor cells. The gene discussed is ANKRD34B; the disease is neoplasm.